Claudin 1 inhibits cell migration and increases intercellular adhesion in triple-negative breast cancer cell line.


Journal

Molecular biology reports
ISSN: 1573-4978
Titre abrégé: Mol Biol Rep
Pays: Netherlands
ID NLM: 0403234

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 18 05 2020
accepted: 09 09 2020
pubmed: 27 9 2020
medline: 19 5 2021
entrez: 26 9 2020
Statut: ppublish

Résumé

Triple-negative "claudin 1 low" subtype represents around 15% of breast cancer and displays poor prognosis. The loss of claudin 1 is correlated with increased invasiveness and higher recurrence of the disease. Claudin 1 constitutes the backbone of the tight junction and is involved in cell-cell adhesion and migration processes. However, studies showed a controversial role of claudin 1 in cell migration. In this study, we aimed to clarify the effect of claudin 1 on migration of mesenchymal triple-negative breast cancer cells (TNBC). We reported that transient over expression of claudin 1 in MDA-MB-231 and Hs578T "claudin 1 low" TNBC cells inhibited cell migration using wound healing and transwell migration assays. In order to investigate more specifically the involvement of claudin 1, we generated stable MDA-MB-231 clones overexpressing claudin 1. Interestingly, the level of claudin 1 was correlated to the inhibition of cell migration and to the increase of cell-cell aggregation associated with enhanced formation of β-catenin adherens junction and occludin tight junction. Finally, we reported for the first time the key role of claudin 1 in the inhibition of cell migration process associated with the disappearance of stress fibers. These data suggest that re-expression of claudin 1 could be a promising strategy for regulating the migration of TNBC which no longer express claudin 1.

Identifiants

pubmed: 32979166
doi: 10.1007/s11033-020-05835-3
pii: 10.1007/s11033-020-05835-3
doi:

Substances chimiques

CLDN1 protein, human 0
Claudin-1 0
Neoplasm Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7643-7653

Auteurs

Marine Geoffroy (M)

Université de Lorraine, CRAN, UMR 7039, 54506, Vandoeuvre-lès-Nancy, France.
CNRS, CRAN, UMR 7039, 54506, Vandoeuvre-lès-Nancy, France.

Alexandra Kleinclauss (A)

Université de Lorraine, CRAN, UMR 7039, 54506, Vandoeuvre-lès-Nancy, France.
CNRS, CRAN, UMR 7039, 54506, Vandoeuvre-lès-Nancy, France.

Sandra Kuntz (S)

Université de Lorraine, CRAN, UMR 7039, 54506, Vandoeuvre-lès-Nancy, France. sandra.kuntz@univ-lorraine.fr.
CNRS, CRAN, UMR 7039, 54506, Vandoeuvre-lès-Nancy, France. sandra.kuntz@univ-lorraine.fr.

Isabelle Grillier-Vuissoz (I)

Université de Lorraine, CRAN, UMR 7039, 54506, Vandoeuvre-lès-Nancy, France.
CNRS, CRAN, UMR 7039, 54506, Vandoeuvre-lès-Nancy, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH